Type V collagen-induced oral tolerance plus low-dose cyclosporine prevents rejection of MHC class I and II incompatible lung allografts.
about
The role of autoimmunity in obliterative bronchiolitis after lung transplantationIncreased frequency of class I and II anti-human leukocyte antigen antibodies in systemic lupus erythematosus and scleroderma and associated factors: a comparative study.Characterization of immune responses to cardiac self-antigens myosin and vimentin in human cardiac allograft recipients with antibody-mediated rejection and cardiac allograft vasculopathyInterleukin-17-dependent autoimmunity to collagen type V in atherosclerosisNeutralizing IL-17 prevents obliterative bronchiolitis in murine orthotopic lung transplantationAntibodies reactive to non-HLA antigens in transplant glomerulopathyType V collagen induced tolerance suppresses collagen deposition, TGF-β and associated transcripts in pulmonary fibrosisAntihuman leukocyte antigen antibody-induced autoimmunity: role in chronic rejection.DNA vaccines for transplantation.Regulatory T cells in lung transplantation--an emerging concept.Lung transplantation: chronic allograft dysfunction and establishing immune tolerance.Th17 Responses to Collagen Type V, kα1-Tubulin, and Vimentin Are Present Early in Human Development and Persist Throughout Life.Intranasal Administration of Type V Collagen Reduces Lung Carcinogenesis through Increasing Endothelial and Epithelial Apoptosis in a Urethane-Induced Lung Tumor Model.A Recombinant G Protein Plus Cyclosporine A-Based Respiratory Syncytial Virus Vaccine Elicits Humoral and Regulatory T Cell Responses against Infection without Vaccine-Enhanced Disease.Immune response to tissue-restricted self-antigens induces airway inflammation and fibrosis following murine lung transplantation.
P2860
Q27008934-49A98803-B879-43DE-B5A0-B0AB67432313Q33418024-B80FB1DE-914C-4245-8B7A-58A4082484A0Q34238488-3BE835BD-A6B5-4690-81C6-BC38E4B52521Q34440352-8B344562-DD96-4EC4-A8AA-231920AA756BQ34874203-E493AD45-07FA-43C8-BEAF-CD583DBE960BQ35012455-C6D2B1E9-BE46-429F-8BA7-794585166377Q35034689-DC5B64FA-B369-4941-A313-D5483D81DE37Q37629539-0A26575E-29C1-4851-8239-CE371BA1E031Q37725897-7C45723C-DAB1-4D84-B42A-2BFD559AD693Q37855647-454DE2D3-EB45-4018-9E85-11D08C939B16Q38224758-D3F64872-42C8-494E-BD68-384E0EE69F23Q39228029-378C631C-1ADE-4A74-A6D7-6B5BCD02B465Q39884884-F12018DE-55B3-452A-9566-D142F03F0F91Q40823850-3B6401A7-2ED8-44FB-A636-37E49894ACF5Q41830532-D5579CDB-C817-4F5A-8406-380FB8DAB75E
P2860
Type V collagen-induced oral tolerance plus low-dose cyclosporine prevents rejection of MHC class I and II incompatible lung allografts.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Type V collagen-induced oral t ...... incompatible lung allografts.
@ast
Type V collagen-induced oral t ...... incompatible lung allografts.
@en
Type V collagen-induced oral t ...... incompatible lung allografts.
@nl
type
label
Type V collagen-induced oral t ...... incompatible lung allografts.
@ast
Type V collagen-induced oral t ...... incompatible lung allografts.
@en
Type V collagen-induced oral t ...... incompatible lung allografts.
@nl
prefLabel
Type V collagen-induced oral t ...... incompatible lung allografts.
@ast
Type V collagen-induced oral t ...... incompatible lung allografts.
@en
Type V collagen-induced oral t ...... incompatible lung allografts.
@nl
P2093
P2860
P356
P1476
Type V collagen-induced oral t ...... I incompatible lung allografts
@en
P2093
David S Wilkes
Heather L Benson
Ichiro Yoshino
Irina Petrache
Kazuhiro Yasufuku
Shigetoshi Yoshida
Yasuo Sekine
Yoshito Yamada
P2860
P304
P356
10.4049/JIMMUNOL.0804028
P407
P577
2009-07-01T00:00:00Z